ArticleAnnals of hematology2025

Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program.

Marco Herling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.